Carcinogenesis Advance Access published online on September 10, 2008
Carcinogenesis, doi:10.1093/carcin/bgn217
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis
Cancer and Polio Research Fund Laboratories, Biosciences Building, University of Liverpool, Crown Street, Liverpool, L69 7ZB, UK
* To whom correspondence and proofs should be addressed : Dr R. Barraclough, Biosciences Building, University of Liverpool, Crown Street, Liverpool, L69 7ZB, UK. e-mail: brb{at}liv.ac.uk, Tel.: 44 151 795 4469, Fax: 44 151 795 4406.
The calcium-binding protein, S100A4 can induce a metastatic phenotype in animal model systems and its expression in various human cancers has been shown to be associated with metastasis and reduced patient survival. Using a series of nested deletion mutants, it is now shown that the two C-terminal lysine residues are required for the enhanced metastasis, invasion and migration abilities that S100A4 confers on cells in a model system of metastasis. Basic C-terminal residues enhance the affinity between S100A4 and its best characterised target, a recombinant C-terminal fragment of non-muscle myosin II heavy chain, isoform A. In wild type S100A4 protein, the presence of the C-terminal lysine, residue 101, enhances the rate of association between S100A4 and non-muscle myosin II heavy chain, isoform A. These results identify the amino acids of S100A4 that are involved in metastasis induction and show that the C-terminal region of S100A4 is a possible target for inhibitors of its metastatic action.
Key Words: breast cancer metastasis calcium-binding proteins S100A4 myosin II
Received June 16, 2008; revised August 15, 2008; accepted September 6, 2008.